By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ProMetic Life Sciences Inc. 

8168 Montview Road

Mount-Royal  Quebec  H4P 2L7  Canada
Phone: 514-341-2115 Fax: 514-341-6227


SEARCH JOBS


Industry
Biotechnology

Segment
Pharmaceuticals





Company News
ProMetic Life Sci (PFSCF.PK)'s PBI-4050 Demonstrates Early Evidence Of Efficacy In Its Idiopathic Pulmonary Fibrosis ("IPF") Phase 2 Clinical Trial 11/17/2016 7:53:00 AM
ProMetic Life Sci (PFSCF.PK) Receives Clearance From Health Canada To Proceed With Its PBI-4050 Placebo-Controlled Phase 2 Clinical Trial In Patients With Metabolic Syndrome And Type 2 Diabetes 11/16/2016 7:48:32 AM
ProMetic Life Sci (PFSCF.PK) Reports Third Quarter 2016 Highlights And Financial Results 11/15/2016 10:59:10 AM
ProMetic Life Sci (PFSCF.PK)'s PBI-4050 Shown To Reduce Pulmonary Hypertension And Lung Remodeling And To Improve Right Ventricular Function In Heart Failure With Reduced Ejection Fraction ("HFrEF") 11/14/2016 7:33:41 AM
Telesta (TSX:TST) Announces Closing Of Arrangement With ProMetic Life Sci (PFSCF.PK) 10/31/2016 9:21:20 AM
Telesta (TSX:TST) Announces Final Court Approval Of Plan Of Arrangement With ProMetic Life Sci (PFSCF.PK) 10/31/2016 7:42:04 AM
ProMetic Life Sci (PFSCF.PK)'s Plasminogen Meets Primary And Secondary End Points In Pivotal Phase 2/3 Trial 10/26/2016 6:21:13 AM
Telesta (TSX:TST) Shareholders Approve Plan Of Arrangement With ProMetic Life Sci (PFSCF.PK) 10/25/2016 10:16:31 AM
ProMetic Life Sci (PFSCF.PK)'s PBI-4050 Meets Primary And Secondary End Points In Metabolic Syndrome And Type 2 Diabetes Phase 2 Clinical Trial 10/20/2016 6:55:08 AM
Leading Independent Advisory Firms ISS And Glass Lewis Recommend Shareholders Vote FOR The Plan Of Arrangement Between Telesta (TSX:TST) And ProMetic Life Sci (PFSCF.PK) 10/12/2016 7:30:01 AM
12345678910...
//-->